Applied DNA Sciences, Inc. (APDN)
NASDAQ: APDN · Real-Time Price · USD
1.760
-0.110 (-5.88%)
At close: Mar 28, 2025, 4:00 PM
1.731
-0.029 (-1.67%)
After-hours: Mar 28, 2025, 7:58 PM EDT
Applied DNA Sciences Revenue
Applied DNA Sciences had revenue of $1.20M in the quarter ending December 31, 2024, with 34.28% growth. This brings the company's revenue in the last twelve months to $3.74M, down -58.46% year-over-year. In the fiscal year ending September 30, 2024, Applied DNA Sciences had annual revenue of $3.43M, down -74.33%.
Revenue (ttm)
$3.74M
Revenue Growth
-58.46%
P/S Ratio
0.11
Revenue / Employee
$77,852
Employees
48
Market Cap
1.94M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 3.43M | -9.94M | -74.33% |
Sep 30, 2023 | 13.37M | -4.80M | -26.43% |
Sep 30, 2022 | 18.17M | 9.14M | 101.25% |
Sep 30, 2021 | 9.03M | 7.10M | 367.40% |
Sep 30, 2020 | 1.93M | -3.46M | -64.16% |
Sep 30, 2019 | Pro | Pro | Pro |
Sep 30, 2018 | Pro | Pro | Pro |
Sep 30, 2017 | Pro | Pro | Pro |
Sep 30, 2016 | Pro | Pro | Pro |
Sep 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
APDN News
- 4 days ago - Applied DNA Submits Validation Package to New York State Department of Health for H5 Bird Flu/Pan-Influenza A Laboratory-Developed Test - Accesswire
- 18 days ago - Applied DNA Announces 1-For-50 Reverse Stock Split Effective March 14, 2025 - Accesswire
- 6 weeks ago - Applied DNA Sciences, Inc. (APDN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress - Accesswire
- 6 weeks ago - Applied DNA to Report First Quarter Fiscal 2025 Financial Results After Market Close on Thursday, February 13, 2025 - Accesswire
- 6 weeks ago - Applied DNA Reminds Shareholders to Vote Ahead of Special Meeting on February 14 - Accesswire
- 2 months ago - Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates - Accesswire
- 2 months ago - Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter - Accesswire